Get an 8-page structured analysis - team, clinical need, competition, regulatory, reimbursement, and market share - in 30 seconds.
No credit card required . 10-days free trial
Built for medtech investors, strategics, and service providers who need fast, structured analysis on any company — without hiring a consultant.
ScopeMedTech is powered by the latest frontier AI models, cross-validated against industry benchmarks and reviewed by experienced human analysts.
A combination of proprietary and public data, industry expertise, and sophisticated algorithms provides high-fidelity analysis.
Identify high-value MedTech opportunities from a crowded landscape and get actionable insight to win them.
ScopeMedtech is easy and intuitive to use. Helps you quantify, track and win new opportunities seamlessly.
Search any medtech company or concept
Get an 8-page structured report in 30 seconds
Download, share, or track it as the company hits milestones
VP of Sales and BD,
Avio MedTech Consulting
Staying on top of a constant stream of early-stage MedTech startups is a grind, and it’s tough to be thorough when you’re buried in a lead pipeline. ScopeMedTech is a great tool I’ve used that actually handles the heavy lifting of multidisciplinary analysis using AI and presents validated output in an easy-to-digest format, so I don’t have to read through a huge amount of text. It’s been huge for backing up my gut feelings on new product concepts with real, quantifiable metrics that actually mean something.
CTO, Nextern Innovation
ScopeMedTech is a concise evaluation of a company and its viability in a market. Great screening tool for gauging level of appropriate engagement for investors, CDMOs, and strategic partners.
Director of BD,
Philips Medisize
Scope Medtech is a powerful tool that helps CDMOs rapidly evaluate the viability of new medical device technologies and companies. It provides a consistent, structured framework for assessing new device ideas, enabling faster, more confident decision-making. Ultimately, it saves time and helps teams prioritize the most promising opportunities.
$499/yr billed annually
Try Free$999/yr billed annually
Try Free$2,499/yr billed annually
Try FreeSpend less time analyzing new leads and more time on winning them
Investors: Screen 10 companies in the time it used to take to screen one. Know which deals deserve deeper diligence before you spend a week on them.
Accelerators & Corp Dev: Evaluate every applicant and acquisition target with the same structured framework: team, clinical need, competition, technical challenge, IP, regulatory, reimbursement, market share.
OEMs and Service providers: Bring strategy in resource allocation. Analyze and prioritize R&D pipeline and startups with a data-backed comprehensive analytics tool.
Most advanced AI analytics tool for MedTech market
Deep expertise in technical, clinical, marketing, regulatory, IP and commercial
Save money and hassle of hiring consultants
Save 5 hours of time per analysis
Instantly get ready to share and present report
Automize lead tracking and pertinent events
Helpful Answers to Support Your Journey